Related Experiment Videos
Node way out.
M S Vaphiades1, H Brown, S M Whitcup
1Departments of Ophthalmology and Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Survey of Ophthalmology
|August 18, 2000
Summary
A patient presented with vision problems and was diagnosed with melanoma-associated retinopathy (MAR). Subsequent tests confirmed malignant melanoma, highlighting the importance of timely diagnosis and treatment for this rare condition.
Area of Science:
- Ophthalmology
- Oncology
- Neuro-ophthalmology
Background:
- Melanoma-associated retinopathy (MAR) is a rare autoimmune condition.
- It can manifest with visual disturbances, often preceding cancer diagnosis.
- Early detection is crucial for managing vision loss and systemic disease.
Observation:
- A 47-year-old woman without prior melanoma history reported visual hallucinations and abnormal visual fields.
- Electroretinography (ERG) results were indicative of MAR.
- A lymph node biopsy confirmed the presence of malignant melanoma.
Findings:
- The patient's symptoms were consistent with melanoma-associated retinopathy.
- Malignant melanoma was diagnosed via lymph node biopsy.
- This case underscores the paraneoplastic nature of MAR.
Implications:
- Prompt ophthalmological evaluation is vital for patients with unexplained visual symptoms.
- MAR can be an early indicator of occult malignancy, necessitating thorough oncological workup.
- Integrated management strategies involving ophthalmology and oncology are essential for optimal patient outcomes.